Jane Street Group, LLC Crispr Therapeutics Ag Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Jane Street Group, LLC holds 171,430 shares of CRSP stock, worth $6.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
171,430
Previous 349,931 51.01%
Holding current value
$6.98 Million
Previous $18.9 Million 57.38%
% of portfolio
0.0%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$44.62 - $62.75 $7.96 Million - $11.2 Million
-178,501 Reduced 51.01%
171,430 $8.06 Million
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $8.95 Million - $11.9 Million
174,859 Added 99.88%
349,931 $18.9 Million
Q1 2024

May 15, 2024
SELL
$60.67 - $89.12 $18.2 Million - $26.7 Million
-299,936 Reduced 63.14%
175,072 $11.9 Million
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $13.5 Million - $25.3 Million
349,887 Added 279.64%
475,008 $29.7 Million
Q3 2023

Nov 14, 2023
BUY
$45.39 - $59.0 $1.3 Million - $1.69 Million
28,650 Added 29.7%
125,121 $5.68 Million
Q2 2023

Aug 14, 2023
SELL
$43.47 - $67.77 $1.64 Million - $2.56 Million
-37,739 Reduced 28.12%
96,471 $5.42 Million
Q1 2023

May 15, 2023
BUY
$41.0 - $56.12 $2.61 Million - $3.57 Million
63,620 Added 90.13%
134,210 $6.07 Million
Q4 2022

Feb 14, 2023
BUY
$39.19 - $65.67 $2.51 Million - $4.2 Million
64,020 Added 974.43%
70,590 $2.87 Million
Q3 2022

Nov 14, 2022
SELL
$61.1 - $83.78 $6.41 Million - $8.78 Million
-104,845 Reduced 94.1%
6,570 $429,000
Q2 2022

Aug 16, 2022
BUY
$43.23 - $73.83 $1.06 Million - $1.8 Million
24,436 Added 28.09%
111,415 $6.77 Million
Q1 2022

May 17, 2022
SELL
$53.19 - $79.24 $11 Million - $16.3 Million
-206,099 Reduced 70.32%
86,979 $5.46 Million
Q4 2021

Feb 15, 2022
BUY
$70.09 - $111.29 $3.08 Million - $4.88 Million
43,882 Added 17.61%
293,078 $22.2 Million
Q3 2021

Nov 16, 2021
SELL
$110.2 - $156.64 $18 Million - $25.5 Million
-162,965 Reduced 39.54%
249,196 $27.9 Million
Q2 2021

Aug 16, 2021
BUY
$100.84 - $161.89 $4.75 Million - $7.62 Million
47,075 Added 12.89%
412,161 $66.7 Million
Q1 2021

May 18, 2021
BUY
$110.72 - $210.04 $20 Million - $38 Million
180,737 Added 98.04%
365,086 $44.5 Million
Q4 2020

Feb 17, 2021
BUY
$79.67 - $173.23 $14 Million - $30.5 Million
175,906 Added 2083.45%
184,349 $28.2 Million
Q3 2020

Nov 17, 2020
BUY
$78.5 - $100.64 $278,596 - $357,171
3,549 Added 72.52%
8,443 $706,000
Q2 2020

Aug 17, 2020
SELL
$38.5 - $76.05 $833,756 - $1.65 Million
-21,656 Reduced 81.57%
4,894 $360,000
Q1 2020

May 15, 2020
BUY
$33.68 - $62.53 $689,934 - $1.28 Million
20,485 Added 337.76%
26,550 $1.13 Million
Q4 2019

Feb 14, 2020
BUY
$36.68 - $73.13 $222,464 - $443,533
6,065 New
6,065 $370,000
Q3 2019

Nov 14, 2019
SELL
$40.99 - $52.56 $488,067 - $625,831
-11,907 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$35.45 - $48.2 $200,150 - $272,137
5,646 Added 90.18%
11,907 $561,000
Q1 2019

May 16, 2019
SELL
$28.02 - $40.87 $925,024 - $1.35 Million
-33,013 Reduced 84.06%
6,261 $224,000
Q4 2018

Feb 15, 2019
SELL
$22.73 - $42.34 $1.1 Million - $2.05 Million
-48,352 Reduced 55.18%
39,274 $1.12 Million
Q3 2018

Nov 14, 2018
BUY
$44.35 - $65.71 $3.44 Million - $5.1 Million
77,674 Added 780.49%
87,626 $3.89 Million
Q2 2018

Aug 15, 2018
SELL
$42.62 - $73.59 $401,523 - $693,291
-9,421 Reduced 48.63%
9,952 $585,000
Q1 2018

May 15, 2018
BUY
$23.52 - $58.17 $455,652 - $1.13 Million
19,373 New
19,373 $886,000

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email